Concepedia

Ibrahim Tolaymat

IT

5

Publications

164

Citations

5

H-Index

2012

Active since

Affiliations

Anglia Ruskin University(Current)

University of Wolverhampton

Qatar University

Ibrahim Tolaymat is an author at Anglia Ruskin University specializing in drug discovery, medicinal chemistry, and medicine.

ORCID

Top concepts

Publications per year

2012–2021

5

Publications

5

Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment

Mohammad Najlah, Ammar Said Suliman, Ibrahim Tolaymat et al. · Pharmaceutics · 2019 · 82 citations · Full text

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines

Ammar Said Suliman, Mouhamad Khoder, Ibrahim Tolaymat et al. · Pharmaceutics · 2021 · 27 citations · Full text

Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives

Finn K. Hansen, Mehdi Khankischpur, Ibrahim Tolaymat et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 21 citations · Full text

, , +9

Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells

Chris Sherer, Ibrahim Tolaymat, Farzana Rowther et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 17 citations · Full text

, , +9

Development, characterization and stability evaluation of ciprofloxacin-loaded parenteral nutrition nanoemulsions

Ammar Said Suliman, Rose Tom, Kirsty Palmer et al. · Pharmaceutical Development and Technology · 2020 · 17 citations

Rows per page

1–5 of 5